MannKind Corp (MNKD)
3.50
-36.82%
MannKind Corp (MNKD) is currently trading at $3.50. This represents a loss of 36.82% from the previous session. With a market capitalization of $1.07B, MNKD is a key component of the Health Care sector. Investors looking to trade MNKD should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade MNKD commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, MannKind Corp (MNKD) shows a bearish trend. Analysts are watching the 5.55 level closely.
Fundamentals
Mkt Cap1.07B
P/E Ratio0.0000
Volume36,584,525
60-Day Technical Chart
Advanced Charting
Need more indicators for MNKD? Use the world's #1 platform.
Open MNKD on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $4
| Metric |
MNKD -36.82% |
IOVA +1.32% |
RXRX +6.80% |
IRWD -11.35% |
|---|---|---|---|---|
| Price | $3.50 | $3.83 | $3.77 | $3.36 |
| Mkt Cap | $1.07B | $1.52B | $1.96B | $0.55B |
| - | View → | View → | View → |
Latest Headlines
MannKind stock tumbles 37% on United Therapeutics inhaler news
Investing.com • Feb 25, 2026
MannKind Target of Unusually High Options Trading (NASDAQ:MNKD)
MarketBeat • Feb 25, 2026
MannKind (MNKD) Sees Stock Drop After Competitor's Product Devel
GuruFocus • Feb 25, 2026
MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’
Stocktwits • Feb 25, 2026
$MNKD stock is down 34% today. Here's what we see in our data.
Quiver Quantitative • Feb 25, 2026
● Gemini Agentic AI Analyst Insight for MNKD
Market Education
- Finding Stocks in the Squeeze Zone: Using Finviz Jun 2, 2024
- Bob Shiller got Nobel Prize - Efficient Frontier in Modern Portfolio Theory Jul 18, 2023
- That suit said read and analyze Market trends. How ? Jul 18, 2023
External Research